Paperpal Prime Logo

Gynecologic Oncology : Impact Factor & More

eISSN: 1095-6859pISSN: 0090-8258

Aims and Scope of Gynecologic Oncology

Gynecologic Oncology is a peer-reviewed medical journal covering all aspects of gynecologic oncology. The journal covers investigations relating to the etiology, diagnosis, and treatment of female cancers, as well as research from any of the disciplines related to this field of interest. It is published by Elsevier and is the official journal of the Society of Gynecologic Oncology. Less

Key Metrics

CiteScore
7.4
Eigenfactor
0.01 - 0.05
H-Index
180
Impact Factor
< 5
Scite Index
0.86 5-Year SI
SJR
Q1Oncology
SNIP
1.54
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Gynecologic Oncology

Gynecologic Oncology Journal Specifications

Overview
Publisher ACADEMIC PRESS INC ELSEVIER SCIENCE
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1972
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Gynecologic Oncology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Gynecologic Oncology

Adjuvant dual HER2 blockade along the HER2-ER axis in APHINITY.
  • 30 Jun 2026
  • Journal of the National Cancer Institute
Welcome reduction of US cervical cancer rates despite state differences.
  • 30 Jun 2026
  • Journal of the National Cancer Institute
Re: Health-related quality of life in patients with newly diagnosed advanced ovarian cancer receiving maintenance olaparib plus bevacizumab (PAOLA-1/ENGOT-ov25).
  • 30 Jun 2026
  • Journal of the National Cancer Institute
Response to Yu, Wang and Ge.
  • 30 Jun 2026
  • Journal of the National Cancer Institute
Outcome of metastatic non-rhabdomyosarcoma soft tissue sarcoma in children and young adults treated on children's oncology group ARST0332 trial.
  • 27 Jun 2026
  • Journal of the National Cancer Institute
RE: Advance care planning impact on caregivers and end-of-life care in advanced cancer.
  • 25 Jun 2026
  • Journal of the National Cancer Institute
Adjuvant dual HER2 blockade along the HER2-ER axis in APHINITY.
  • 30 Jun 2026
  • Journal of the National Cancer Institute
Welcome reduction of US cervical cancer rates despite state differences.
  • 30 Jun 2026
  • Journal of the National Cancer Institute
Re: Health-related quality of life in patients with newly diagnosed advanced ovarian cancer receiving maintenance olaparib plus bevacizumab (PAOLA-1/ENGOT-ov25).
  • 30 Jun 2026
  • Journal of the National Cancer Institute
Response to Yu, Wang and Ge.
  • 30 Jun 2026
  • Journal of the National Cancer Institute
Outcome of metastatic non-rhabdomyosarcoma soft tissue sarcoma in children and young adults treated on children's oncology group ARST0332 trial.
  • 27 Jun 2026
  • Journal of the National Cancer Institute
RE: Advance care planning impact on caregivers and end-of-life care in advanced cancer.
  • 25 Jun 2026
  • Journal of the National Cancer Institute

FAQs on Gynecologic Oncology